Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has ongoing diagnostic programs in oncology, hematology, cardiology and women's health with an initial focus in ovarian cancer. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at http://www.vermillion.com.

Contact Information

12117 Bee Cave Road
Building Two, Suite 100
Austin, TX 78731

tel: 510-505-2100
fax: 510-505-2101


Investor Relations



Exchange: NASDAQ
Industry: Scientific & Technical Instruments
Market Cap: $112.6M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.